Pilot Study of Cisplatin, Etoposide, Bleomycin, and Escalating Dose Cyclophosphamide Therapy for Children With High Risk Germ Cell Tumors: A Report of the Children’s Oncology Group (COG)

BACKGROUND: To establish the maximum tolerated dose (MTD) and toxicity profile of cyclophosphamide with cisplatin, etoposide, and bleomycin (C-PEB) in children with high-risk malignant germ cell tumors (HR-MGCT). PROCEDURE: Eligibility criteria included untreated patients ≤ 21 years of age with stag...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pediatr Blood Cancer
Main Authors: Malogolowkin, Marcio H., Krailo, Mark, Marina, Neyssa, Olson, Thomas, Frazier, A. Lindsay
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4303038/
https://ncbi.nlm.nih.gov/pubmed/23703725
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.24601
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados